Jacobs Levy Equity Management Inc. purchased a new stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 292,433 shares of the company's stock, valued at approximately $49,836,000.
Several other hedge funds also recently made changes to their positions in PG. Nuveen LLC bought a new stake in shares of Procter & Gamble during the first quarter valued at approximately $1,954,941,000. GAMMA Investing LLC boosted its holdings in Procter & Gamble by 20,758.5% in the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after acquiring an additional 7,913,335 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after acquiring an additional 2,466,308 shares in the last quarter. Invesco Ltd. boosted its holdings in Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after acquiring an additional 2,228,151 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Procter & Gamble by 15.8% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock worth $2,728,430,000 after acquiring an additional 2,224,912 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on PG shares. JPMorgan Chase & Co. restated a "neutral" rating and issued a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Barclays set a $164.00 price target on Procter & Gamble and gave the stock an "equal weight" rating in a research note on Thursday, July 31st. Evercore ISI restated an "in-line" rating and issued a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Wells Fargo & Company decreased their price target on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Finally, BNP Paribas reiterated an "outperform" rating and set a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $175.12.
Read Our Latest Research Report on Procter & Gamble
Insider Activity at Procter & Gamble
In related news, CFO Andre Schulten sold 11,638 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the completion of the transaction, the chief financial officer directly owned 52,642 shares of the company's stock, valued at approximately $8,279,007.34. This represents a 18.11% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Marc S. Pritchard sold 9,849 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,548,952.23. Following the transaction, the insider directly owned 182,422 shares of the company's stock, valued at approximately $28,689,507.94. The trade was a 5.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 120,181 shares of company stock valued at $18,918,012 in the last 90 days. 0.18% of the stock is currently owned by insiders.
Procter & Gamble Stock Performance
PG traded down $0.90 during midday trading on Monday, reaching $159.12. The company had a trading volume of 7,175,827 shares, compared to its average volume of 6,145,017. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The business has a 50-day moving average of $156.41 and a two-hundred day moving average of $162.14. The company has a market cap of $372.42 billion, a P/E ratio of 24.44, a P/E/G ratio of 4.22 and a beta of 0.36. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. During the same quarter in the prior year, the business posted $1.40 earnings per share. The business's quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were given a dividend of $1.0568 per share. The ex-dividend date was Friday, July 18th. This represents a $4.23 annualized dividend and a dividend yield of 2.7%. Procter & Gamble's dividend payout ratio (DPR) is currently 64.82%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report